Furthermore, MM-derived Galectin-1 mediates the pro-tumorigenic effects of M-MDSCs by interacting with CD304 on M-MDSCs and facilitates MM progression following autologous stem cell transplantation (ASCT) [85]. Here, LGALS1 is linked to Miyoshi myopathy.